Neuphoria Therapeutics Inc. (NEUP)

NASDAQ: NEUP · Real-Time Price · USD

4.150

-0.210 (-4.82%)

At close: Feb 27, 2026, 4:00 PM EST

4.300

+0.150 (3.61%)

After-hours: Feb 27, 2026, 5:57 PM EST

Neuphoria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	22	13	-	-	-	-
Enterprise Value	0	-4	-	-	-	-
Last Close Price	4.15	7.10	-	-	-	-
PS Ratio	1.49	0.85	-	-	-	-
PB Ratio	0.75	0.70	-	-	-	-
P/TBV Ratio	1.36	2.40	-	-	-	-
P/FCF Ratio	-	172.83	-	-	-	-
P/OCF Ratio	-	172.83	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.02	0.01	0.02
Debt / FCF Ratio	-	1.93	-	-	-	-
Net Debt / Equity Ratio	-0.74	-0.74	-0.70	-0.53	-0.58	-0.58
Net Debt / EBITDA Ratio	18.45	84.56	0.72	0.56	1.97	2.96
Net Debt / FCF Ratio	9.37	-182.08	0.84	0.80	1.51	3.67
Asset Turnover	0.55	0.56	-	-	0.10	0.02
Quick Ratio	8.76	3.37	3.33	4.58	12.02	12.55
Current Ratio	9.04	3.56	3.45	4.87	12.46	13.10
Return on Equity (ROE)	-26.07%	-2.03%	-78.44%	-71.40%	-41.64%	-28.86%
Return on Assets (ROA)	-4.25%	-1.84%	-39.58%	-37.41%	-18.40%	-14.48%
Return on Capital Employed (ROCE)	-5.50%	-3.40%	-74.70%	-83.50%	-28.40%	-19.80%
Earnings Yield	-25.32%	-2.77%	-	-	-	-
FCF Yield	-10.56%	0.58%	-	-	-	-
Buyback Yield / Dilution	-123.33%	-95.01%	99.94%	-8.53%	-73.52%	-43.14%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q